Therapeutic Antibody Webinar – Reduce Risk in VHH and BsAb Discovery with Early Immunogenicity Assessment 07-02-2026 / Dr. Derek Chen, Sr. Director, Antibody Drug Discovery Dept., Pro Accelerating VHH and bispecific antibody development is no longer just about speed, it’s about progressing the right candidates with confidence. Early insights into safety, immunogenicity, and developability are critical to reducing costly downstream risk Learn More
Therapeutic Antibody Accelerating In Vivo CAR-T Antibody Discovery and Development 04-09-2026 / Derek Chen, Sr. Director, Antibody Drug Discovery Dept., ProBio In vivo CAR-T therapy transforms T cells directly within the body, making treatment faster, simpler, and more accessible, with the potential for repeat dosing and targeting solid tumors. Antibodies guide CAR constructs to tumor-specific antigens, enabling Learn More
Therapeutic Antibody sdAb Discovery & ExpressCMC™ with Cell Line Development Webinar 09-23-2025 / Derek Chen, Sr. Director, Antibody Drug Discovery Dept., ProBio...... sdAbs are unique type of antibodies derived from camelids and widely used as therapeutics, especially as building blocks for multi-specific antibodies. Learn More
Therapeutic Antibody Biologics Webinar: From Lab Bench to GMP for BsAb & ADC 07-31-2025 / Join us for an insightful seminar focused on the discovery and development of complex biologics, including bispecific antibodies (BsAbs) and antibody-drug conjugates (ADCs) Learn More
Therapeutic Antibody Bispecific Antibody Webinar | Advancing Challenging Biologics BsAb, ADC & RDC 06-05-2025 / The BioForum ‘Advancing Challenging Biologics: BsAb, TsAb and RDC/ADC Innovations’, delivered by BioMelbourne Network in collaboration with ProBio, will discuss how the development of complex biologic therapies – including bi-specific and tri-specific ... Learn More
Therapeutic Antibody Biologics Webinar | Biologics CMC Regulatory, Process & Tech Transfer 03-08-2025 / Tina Yu, Sr. Director of Regulatory Affairs Dept., ProBio As the biologics field rapidly evolves, mastering regulatory pathways, process development, and tech transfer is essential for success. Gain key insights to drive innovation and overcome challenges. Learn More
Therapeutic Antibody Antibody Discovery Webinar | Functional Antibody Lead Discovery & Engineering 03-04-2025 / Derek Chen, Sr. Director, Antibody Drug Discovery Dept. ProBio Functional screening is the most crucial step for the early-stage therapeutic antibody discovery. Currently, most of antibody lead discovery strategy starts with screening for binders, followed by functional characterization with purified antibody. Learn More
Therapeutic Antibody Pre-clinical DMPK Study and Generation of Toolbox to Facilitate PK/ADA Analysis 02-25-2025 / Derek Chen, Sr. Director, Antibody Drug Discovery Dept. Animal based DMPK analysis is a crucial component in pre-clinical study of drug candidate. Learn More